DEADLINE EXTENDED
NCCRED Clinical Research Scholarship applications - close THIS SUNDAY
Don't miss out!
The NCCRED Clinical Research Scholarship Program aims to build the scope and capacity of clinical research on emerging drugs across the drug and alcohol sector. This is a national program open to clinicians at all levels, anywhere in Australia. The TWO competitive rounds offer financial and research support allowing recipients to conduct a new research project.
The rounds will have a focus on the following areas:
Nursing and allied health professionals
Preferred candidates for this Scholarship round will be practicing alcohol and other drugs nurses and allied health professionals, though applications are open to all clinicians working within the AOD sector.
Aboriginal or Torres Strait Islander health professionals
Scholarships will be open to practicing Aboriginal or Torres Strait Islander health professionals (clinicians, nurses, allied health workers) in the alcohol and other drugs sector.
Applications now close this weekend Sunday 8 November 2020 at 12pm AEDT.
NCCRED symposium: Innovations in therapeutic practice
Friday 20th November 11am - Registrations OPEN!
We wish we could see you all face to face, but this year it will be done virtually to accommodate COVID-19 restrictions.
The 2020 symposium will focus on innovations in therapeutic practice for methamphetamine disorder. The symposium brings together leading national researchers, including presentations from recipients of NCCRED’s Round 2 Seed Funding Program. Recipients will share the most up-to-date aspects of their work and research around methamphetamine and emerging drug use.
Guest International Presenter: Dr David Goodman-Meza
David Goodman-Meza, MD, MAS, is an Assistant Professor in the Division of Infectious Diseases at the David Geffen School of Medicine at University of California, Los Angeles, USA. Dr. Goodman-Meza is a Mexican-American physician-scientist.
He is a recipient of an NIDA K08 Career Development Award where he is training in the use of natural language processing and machine learning to evaluate outcomes of people who inject drugs who are admitted due to Staphylococcus aureus bacteremia. He is also the Los Angeles principal investigator on a NIDA Clinical Trials network study evaluating buprenorphine for treatment of methamphetamine use disorder.
The Symposium Program will be available shortly. For More information visit our website
Register now for the Symposium - registration is free
Good Clinical Practice training (ICH-GCP) - expressions of interest
GCP training is essential for anyone involved in clinical trials and in clinical research as it provides the fundamentals for the conduct of ethical research. NCCRED provides training and certification to clinicians and academics in the Drug and Alcohol Sector as a key element to its research education agenda. Participants who complete the training receive Transcelerate-accredited certification which is internationally recognised and valid for up to 3 years.
NCCRED is seeking expressions of interest to run a course of GCP training online, over a series of sessions via Zoom.
The National Centre for Clinical Research on Emerging Drugs is made up of a consortium of the following four institutions
|
|
 |  |
Please unsubscribe if you no longer wish to receive these emails.
